D. Scott Neal’s Amgen AMGN Stock Holding History

D. Scott Neal’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-50	Closed	-$9K	–	164
2017 Q3	$9K	Sell	50 -50	-50%	-$8.86K	0.01%	133
2017 Q2	$17K	Hold	100	–	–	0.01%	128
2017 Q1	$16K	Hold	100	–	–	0.01%	108
2016 Q4	$15K	Buy	+100	New	+$15.1K	0.01%	104

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D. Scott Neal's AMGN Position: Q4 2017 in Review

D. Scott Neal sold out of Amgen (AMGN) in Q4 2017, closing a stake of 50 shares — an estimated $9K sold.

D. Scott Neal first reported a position in AMGN in Q4 2016 and held it in 4 quarters. The position peaked at $17K in Q2 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

D. Scott Neal reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
D. Scott Neal sold 50 Amgen shares in Q4 2017, an estimated $9K.
D. Scott Neal first reported a position in Amgen in Q4 2016 and held it in 4 quarters.
D. Scott Neal's Amgen position peaked at $17K in Q2 2017.
1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on D. Scott Neal's 13F filing for Q4 2017, filed 16 Feb 2018.